Protect your young infant against COVID-19 while contributing to important medical research.
Although for most children COVID is similar to most common respiratory, we know that infants are at higher risk for severe disease including hospitalization and pediatric intensive care unit (PICU) admission.
Our center is participating in a nationwide vaccine study to study the use of the moderna COVID-19 vaccine in children ages 3 months to 6 months.
We have given the moderna vaccine to hundreds of infants aged 6 months and up and have had an excellent response to these vaccines in this age group so anticipate a similar response in younger infants.
Our hope is that by participating in this trial, we can help to expand access to COVID-19 vaccines to the youngest and one of the most vulnerable ages.
By participating in this study, you contribute to advancing medical research AND are compensated for your time and participation.
To learn more and see if your child qualifies, fill out this form and our team will reach out to tell you more and find out if your child is a good fit for the study.